Trialect

+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

Glenn Foundation for Medical Research (GFMR) Discovery Award

American Federation for Aging Research

The Glenn Foundation for Medical Research (GFMR) in collaboration with the American Federation for Aging Research (AFAR), has established the Glenn Foundation Discovery Award. This Award was created to support research projects with strong potential to develop pioneering discoveries for understanding the underlying biological mechanisms that govern normal human aging and its related physiological decline. Relevant proposals from any branch of biology are eligible. This funding program specifically seeks to include principal investigators who may not have previously worked in the area of aging, but whose research and expertise are applicable to understanding the biological mechanisms of normal aging and its relevance to age-associated health decline.

Projects that characterize aging as a disease, or that focus on specific diseases are discouraged unless the research plan provides direct connections to the biology of aging and/or the prospect of a translational discovery relevant to improving human healthspan.

Specialties

Cell Biology

Molecular Biology

Geriatrics & Gerontology

Physiology

Eligibility Requirements

To be eligible, the applicant :

Must be a full-time faculty member at the rank of Assistant Professor or higher at the time of the LOI deadline. To be competitive at the Assistant Professor level, a candidate would be expected to have established R01 or equivalent funding. The Glenn Foundation Discovery Award does not substitute for the R01 funding mechanism, but supports new, rather than incremental, research projects in established laboratories.
Must have a strong record of independent publication beyond the postdoctoral level
Cannot be a Principal Investigator supported through the Paul F. Glenn Centers for Biology of Aging Research.
Must conduct the proposed research at qualified not-for-profit setting in the United States.

Investigators who may not have previously worked in the area of aging, but whose research interests and expertise are relevant and could lead to discoveries in understanding the biology of normal aging are encouraged to apply.

Former AFAR Research Grant for Junior Faculty awardees may apply; former Glenn Foundation Breakthrough In Gerontology (BIG) awardees may NOT apply. If you are applying for an AFAR Grant for Junior Faculty and Glenn Foundation for Medical Research Grants for Junior Faculty, you may NOT also apply for the 2025 Glenn Foundation Discovery Award.

Questions about eligibility and suitability of research project can be addressed to grants@afar.org.

Eligible Countries:

United States

Sponsor Details

Sponsor Institute/Organizations: American Federation for Aging Research

Sponsor Type:

Address: AFAR,55 West 39th Street, 16th Floor New York, NY 10018

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity